0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Biological and Virologic Characteristics of Primary HIV Infection

Timothy W. Schacker, MD; James P. Hughes, PhD; Theresa Shea, PAC; Robert W. Coombs, MD, PhD; and Lawrence Corey, MD
[+] Article and Author Information

From the University of Washington and the Fred Hutchinson Cancer Research Center, Seattle, Washington. Acknowledgments: The authors thank Ann C. Collier, MD, for assistance with protocol design and manuscript review; Eric Peterson and the staff of the University of Washington Retrovirology Laboratory for their dedication and hard work; and the study participants for their dedication and commitment. Grant Support: In part by grants AI-26657, AI-01228, AI-45206, and AI-35605 from the National Institutes of Health. Requests for Reprints: Lawrence Corey, MD, Fred Hutchinson Cancer Research Center, 1124 Columbia Street (M-115), Seattle, WA 98104. Current Author Addresses: Dr. Schacker: Department of Medicine, Box 250, University of Minnesota, 516 Delaware Street SE, Minneapolis, MN 55455.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1998;128(8):613-620. doi:10.7326/0003-4819-128-8-199804150-00001
Text Size: A A A

Background: The clinical events surrounding acute HIV-1 infection have been well described, but little is known about whether the virologic course of acute HIV-1 infection influences the subsequent progression of disease.

Objective: To define the virologic natural history of acute and very early HIV infection.

Design: Prospective, longitudinal cohort study.

Setting: University of Washington Research Clinic

Participants: 74 adults enrolled soon after acquisition of HIV (mean, 69 days).

Measurements: Plasma HIV-1 RNA levels; quantitative cell cultures; CD4 cell counts; and detailed clinical assessments done at study entry, biweekly for 1 month, monthly for 2 months, and quarterly thereafter.

Results: In the first 30 days after acquisition of HIV, HIV-1 RNA levels varied greatly among participants (range, 27 200 to 1.6 × 106 copies per mL of plasma). Levels of HIV-1 RNA decreased by a mean of 6.5% per week for the first 120 days and then increased by a mean of 0.15% per week. CD4 cell counts decreased by a mean of 5.2 cells/mm3 per week for the first 160 days and by a mean of 1.9 cells/mm3 per week thereafter (P < 0.01). Disease progressed faster in participants who sought medical care for their acute seroconversion syndrome (P = 0.01) and those who had high plasma HIV-1 RNA levels 120 to 365 days after acquisition (P < 0.01). Peak levels in the first 120 days were not predictive of disease progression.

Conclusions: The variability in viral RNA levels associated with acute HIV-1 infection is greater than previously appreciated. Within 120 days of acquisition, plasma HIV RNA levels rapidly decrease to an inflection point, after which they gradually increase. Virus-host interactions soon after acquisition seem to have a major influence on the long-term outcome of HIV-1 disease.

Figures

Grahic Jump Location
Figure 1.
Scatterplot of plasma HIV-1 RNA levels (x103/mL) and median plasma HIV-1 RNA levels in the cohort from the time of seroconversion.
Grahic Jump Location
Grahic Jump Location
Figure 2.
Participants with initially low and subsequently high plasma HIV-1 RNA levels.topbottom

Plasma HIV RNA levels (×) and CD4 cell counts (o) are plotted from the time of study entry. Each point represents the median value for the 0- to 3-, 4- to 6-, 7- to 9-, 10- to 12-, and 13- to 15-month intervals after acquisition. Both participant 1 ( ) and participant 2 ( ) had relatively low plasma HIV RNA levels in the first 4 months after acquisition and subsequent increase in viral level and rapid rate of CD4 cell loss.

Grahic Jump Location
Grahic Jump Location
Figure 3.
Kaplan-Meier analysis of time to a CD4 cell count of 300 cells/mm3 or less for persons who consulted a physician about symptoms of HIV seroconversion (dotted line) and those who did not (solid line).
Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)